CD8B and neoplasm: Some, like CD69 were upregulated at d2 in the tumor, and a number of genes including CD8a and CD8b1 are downregulated in the tumor at d2 (Supplementary Fig. 1); however, these changes were not significant when corrected for multiple comparisons.